News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VG Life Sciences, Inc. (VGLS) December 2013 Shareholder Letter



12/18/2013 1:39:30 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA BARBARA, Calif., Dec. 18, 2013 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc., VGLS (formerly known as Viral Genetics) is a Santa Barbara, California-based biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 50 US and international patents and pending patents protecting its exclusive biotech platform technologies. Today the Company posted on its website (www.vglifesciences.com) the following December 2013 Shareholder Letter:

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES